According to the latest report from the China Association for Medical Devices Industry, the market size of rehabilitation robots in China reached 8.7 billion yuan in 2023, a year-on-year increase of 32%, and is expected to exceed 12 billion yuan by 2025. Currently, more than 50 domestic companies have entered the rehabilitation robotics sector, with products covering multiple body parts including the upper limbs, lower limbs, hands, and ankle joints, and technologies spanning cutting-edge fields such as exoskeletons, soft robotics, and brain-computer interfaces.
At the recent International Rehabilitation Engineering Conference, several Chinese companies showcased next-generation rehabilitation robots, such as Fourier Intelligence's ExoMotus lower limb exoskeleton robot, which enables gait training and real-time data feedback, and Shenzhen Milebot's BEAR-H1 hand rehabilitation robot, which uses flexible drive technology and is suitable for post-stroke hand function recovery. These devices have been adopted in over 600 hospitals nationwide, including partner hospitals.
Background and Significance
The rapid rise of China's rehabilitation robotics industry is attributed to multiple factors: an aging population intensifying the demand for rehabilitation services for conditions such as stroke and spinal cord injury; increased policy support, with the National Medical Products Administration accelerating the approval of innovative medical devices; and technological breakthroughs, such as artificial intelligence, sensors, and lightweight materials, making devices smarter and more user-friendly. According to statistics from the Chinese Journal of Rehabilitation Medicine, China faces a shortage of 100,000 rehabilitation therapists, and rehabilitation robots can partially alleviate this manpower pressure while improving treatment efficiency.
Significance for International Patients
For international patients, China's rehabilitation robotics industry offers new options. Compared to similar equipment from Europe and the United States, domestically produced rehabilitation robots are 30%-50% lower in price, with comparable technology, and some products have obtained CE certification in the EU. For example, a top-tier hospital in Shanghai introduced a domestically produced upper limb rehabilitation robot, reducing treatment costs by approximately 20% compared to traditional manual therapy. International patients can learn about treatment costs through the cost estimator and schedule rehabilitation assessments on the medical services page.
How Mei Jia Kang Can Help
As a cross-border medical platform, Mei Jia Kang collaborates with several top rehabilitation hospitals in Shanghai to provide international patients with consultation and appointment services for rehabilitation robot therapy. Our medical team will match suitable robotic rehabilitation plans based on each patient's condition and assist with visa arrangements, translation, and follow-up care. For more details on the process, feel free to contact us. We will continue to monitor the latest advancements in rehabilitation robotics to provide patients with cutting-edge information.
Related reading: Overview of Partner Hospitals in Shanghai